Clinical decision making using ovarian cancer risk assessment.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20093593.
- Also identified by DOI 10.2214/AJR.09.3669.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although any adnexal abnormality found at imaging can be concerning for an ovarian malignancy, the clinician must perform an evaluation to decide if the actual likelihood of malignancy justifies the risk of surgery. When determining the likelihood of an asymptomatic, incidental adnexal mass being malignant, the provider must answer one important question: Do the clinical findings warrant the potential morbidity of surgery? This article will focus on the decision making that goes into such an evaluation. A patient's medical history, physical examination, CA-125 level, and imaging characteristics are all factors that impact the ultimate decision of whether a patient can be observed with repeat imaging or should proceed to surgical evaluation.
Medical subject headings
- Decision Making
- Diagnostic Imaging
- Ovarian Neoplasms
- Risk Assessment